Full article view 2017-09-21T12:08:00+00:00
Back to News & Insights »

Unique Methodologies Help Meet Reimbursement Requirements for Oncology Treatment in European Countries

Citing concerns about the methods used to estimate overall survival, a European payer objected to the reimbursement cost-effectiveness analysis submitted by an oncology product manufacturer. Learn how a global systematic literature review and meta-analysis provided a platform for a compelling response.

Get the case study

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.